洞察市场格局
解锁药品研发情报

400客服电话

  • 购买数据产品

    400-9696-311 转1

  • 定制咨询业务

    400-9696-311 转2

  • 数据与AI定制业务

    400-9696-311 转3

  • 商务合作及其他问题

    400-9696-311 转4

  • 投诉及建议

    400-9696-311 转5

医药数据查询

【ChiCTR2600116880】Effect of a Health Education Program on Lung Cancer Screening among College Students Who Smoke

基本信息
登记号

ChiCTR2600116880

试验状态

结束

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2026-01-16

临床申请受理号

/

靶点

/

适应症

Lung Cancer (Screening and Prevention)

试验通俗题目

Effect of a Health Education Program on Lung Cancer Screening among College Students Who Smoke

试验专业题目

Efficacy of the Health Belief Model-Based Intervention in Enhancing Lung Cancer Screening among Smoker Collegians: A Randomized Controlled Trial

申办单位信息
申请人联系人
请登录查看
申请人名称
请登录查看
联系人邮箱
请登录查看
联系人邮编

联系人通讯地址
请登录查看
临床试验信息
试验目的

This study aims to examine the efficacy of Health Belief Model–based intervention in enhancing lung cancer screening among smoker collegians.

试验分类
请登录查看
试验类型

随机平行对照

试验分期

其它

随机化

Randomization Procedure: Once the final sample had been confirmed, the 144 students who agreed to take part in the study were assigned to a study group (intervention group) and a control group (non-intervention group) using a simple random assignment procedure. All participants’ names were written on identical pieces of paper and placed in a container, which was mixed well. One student then drew the papers one by one; the first name was placed in the study group, the next in the control group, and this process continued alternately until all 144 participants had been assigned. Sign the informed consent: All participants provided written informed consent in Arabic. Length of follow-up (include time point of outcome measure): 14 days (from baseline to post-intervention measurement)

盲法

Participants and educators were aware of group assignments due to the nature of the educational intervention; outcome assessors were blinded where possible.

试验项目经费来源

Self-funded / No external funding

试验范围

/

目标入组人数

72

实际入组人数

/

第一例入组时间

2025-10-01

试验终止时间

2025-11-26

是否属于一致性

/

入选标准

1. University students currently enrolled at the University of Telafer; 2. Current smokers; former smokers within the past 15 years; or individuals with a smoking history of one pack per day for 30 years; 3. Aged 18 years and above; 4. Able to read and understand Arabic; 5. Willing to participate and provide informed consent.;

排除标准

1. Students diagnosed with lung cancer or any other chronic disease; 2. Non-smokers; 3. Students who have previously participated in an educational program related to lung cancer or had undergone lung cancer screening using a low-dose CT scan.;

研究者信息
研究负责人姓名
请登录查看
试验机构

College of Nursing, University of Baghdad

研究负责人电话
请登录查看
研究负责人邮箱
请登录查看
研究负责人邮编

/

联系人通讯地址
请登录查看
更多信息
获取更多临床信息查看权限
立即前往摩熵医药企业版免费查询
示例数据
<END>

最新临床资讯

摩熵医药企业版
50亿+条医药数据随时查
7天免费试用

全球药物研发中心
全球研发数据与行业前沿情报

384,225
全球在研药物数
1,205
本月临床试验数
全球批准的新药
更多
全球首批
各国首批
数据来源:摩熵医药
更新时间:
研发动态
相关报告
政策法规
更多信息,请进入全球药物研发中心查看

医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测

2,630亿元
2026年Q2总销售额
6.14%(2026Q2)
TOP5企业市场份额
药品销售排行榜
查看完整数据
2025Q4医院化学药销售增速 *按市场份额排序
  • 1
    甲氨蝶呤注射液
  • 2
    克霉唑阴道乳膏
  • 3
    氯化钠注射液
核心能力
  • 医药市场销售数据分析 · 医院、实体药店、网上药店
  • 市场竞争格局分析(靶点、药品类型、ATC大类)
更多信息,请进入医药市场洞察中心查看